Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by CRC Press, 2022
ISBN 10: 1032338474ISBN 13: 9781032338477
Seller: Basi6 International, Irving, TX, U.S.A.
Book
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Published by CRC Press, 2022
ISBN 10: 1032338474ISBN 13: 9781032338477
Seller: WorldofBooks, Goring-By-Sea, WS, United Kingdom
Book
Paperback. Condition: Fine.
Published by CRC Press 2022-06-13, Boca Raton, 2022
ISBN 10: 1032338474ISBN 13: 9781032338477
Seller: Blackwell's, London, United Kingdom
Book
paperback. Condition: New. Language: ENG.
Published by Taylor & Francis Ltd, 2022
ISBN 10: 1032338474ISBN 13: 9781032338477
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Book
Paperback / softback. Condition: New. New copy - Usually dispatched within 4 working days.
Published by CRC Pr I Llc, 2022
ISBN 10: 1032338474ISBN 13: 9781032338477
Seller: Revaluation Books, Exeter, United Kingdom
Book
Paperback. Condition: Brand New. 2nd edition. 576 pages. 9.00x6.00x1.00 inches. In Stock.
Published by CRC Press, 2022
ISBN 10: 1032338474ISBN 13: 9781032338477
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Sarfaraz K. Niazi, Ph.D., a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines. He is Founder and Executive Chairman of Adello Biologics.